Ultra Market Research | Global Pharmaceutical Chemicals Market
Global Pharmaceutical Chemicals Market
Report ID : 895
Category : Pharmaceuticals,Chemicals,Global
No Of Pages : 137
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Pharmaceutical Chemicals Market
Introduction Global Pharmaceutical Chemicals Market encompasses a wide range of chemical compounds utilized in the formulation and production of pharmaceutical drugs. These chemicals play a critical role in the manufacturing of active pharmaceutical ingredients (APIs) and excipients, which ensure the efficacy, safety, and stability of medicines. Applications of pharmaceutical chemicals span various therapeutic segments, including oncology, cardiovascular diseases, and infectious diseases. Recent trends indicate the increasing adoption of green chemistry and biotechnology-based manufacturing processes due to the rising regulatory emphasis on sustainability. The market size was estimated to be around USD 150 billion in 2023, and it is expected to have a steady growth rate over the next decade because of the increasing demand for innovative drugs and an expanding geriatric population. The market scenario reflects robust investments in research and development, especially in emerging economies.
Segmentation Therapeutic Applications • Oncology o Anticancer Agents o Hormonal Therapies o Immunotherapeutic Compounds o Others • Cardiovascular Diseases o Antihypertensive Drugs o Anticoagulants o Antiarrhythmics • Infectious Diseases o Antibiotics o Antiviral Drugs • Others o Neurological Disorders o Endocrine Disorders
Chemical Type • Active Pharmaceutical Ingredients (APIs) o Synthetic Chemicals o Biochemical APIs o Others • Excipients o Binders o Fillers o Preservatives • Intermediates o Bulk Intermediates o Fine Intermediates
End-Use • Pharmaceutical Companies o Branded Drug Manufacturers o Generic Drug Manufacturers • Research and Development Institutions o Academic Research Centers o Contract Research Organizations (CROs) • Others o Biopharmaceutical Companies o Hospitals
List of Market Players 1. BASF SE (Germany) 2. Dow Inc. (United States) 3. Pfizer Inc. (United States) 4. Johnson & Johnson (United States) 5. Merck KGaA (Germany) 6. AstraZeneca (United Kingdom) 7. Novartis AG (Switzerland) 8. Sanofi (France) 9. Lonza Group (Switzerland) 10. Gilead Sciences (United States) 11. Bayer AG (Germany) 12. GlaxoSmithKline (United Kingdom) 13. Teva Pharmaceutical Industries Ltd. (Israel) 14. AbbVie Inc. (United States) 15. Boehringer Ingelheim (Germany)
Drivers Main driver of the Global Pharmaceutical Chemicals Market is the growing prevalence of chronic and infectious diseases, leading to an increased demand for innovative therapeutics. Increasing healthcare expenditure in response to an aging population has further led to the growth in pharmaceutical production. The developments in drug discovery, especially in targeted therapies and biologics, have dramatically enhanced the demand for high-quality pharmaceutical chemicals. Stringent regulatory frameworks on drug safety and efficacy further push the development of higher-quality APIs and excipients. The expansion of pharmaceutical manufacturing hubs in emerging markets, along with increased investments in R&D, is also positive for the market's trajectory.
Restraints Despite the growth, challenges remain in the Global Pharmaceutical Chemicals Market, for instance, regulatory compliance. This is due to its cost and complexity in the development of drugs. It also has price volatility in raw materials and supply chain disruptions, especially in response to pandemics across the globe. High initial investment requirements for manufacturing facilities and R&D labs discourage new entrants. This also increases the threat of alternative therapy, like personalized medicine, to traditional pharmaceutical chemical applications.
Opportunities Opportunities present themselves through emerging markets within Global Pharmaceutical Chemicals Market given increased healthcare access and favorable government support. Green chemistry and biotechnology-based techniques unlock new sustainable solutions toward chemical production. Pharmaceutical company collaboration with CMO will help the outsourcing of pharmaceutical chemicals for reduced operational expenses. There is also great opportunities in biosimilars as well as specialty drugs.
Trends Major green and sustainable manufacturing practice follows the trend within the Global Pharmaceutical Chemicals Market. Companies are progressively focusing their investments on developing APIs and excipients of bio-based kinds. Secondly, the world of pharmaceutical manufacturing is embracing a kind of digitalisation: they are adopting newer technologies to optimize chemical processes that also depend on AI, and IoT. Finally, in high potency API (HPAPIs), the market trends witness strong potential for oncology as well as rare diseases treatment. Regulatory harmonization between the US, Europe and the Asia-Pacific countries also eases trade flow and innovation.
Approved Products and Pipeline • Approved: Dapagliflozin, Pembrolizumab, and Abiraterone. • Pipeline: Etrasimod, Tirzepatide, and Donanemab.
They are used in drug formulation, manufacturing APIs, and excipients.
North America leads due to advanced healthcare infrastructure and high R&D investments.
Rising chronic disease prevalence, growing aging population, and innovation in drug discovery.
Companies like BASF, Pfizer, Novartis, and Sanofi dominate the industry.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Chemical Type • Active Pharmaceutical Ingredients (APIs) o Synthetic APIs o Biochemical APIs o Others • Excipients o Fillers o Binders o Preservatives • Intermediates o Bulk Intermediates o Fine Intermediates 3.2.2 By Therapeutic Application • Oncology o Anticancer Agents o Immunotherapy Drugs o Hormonal Therapies • Cardiovascular Diseases o Anticoagulants o Beta-Blockers o Antiarrhythmics • Neurological Disorders o Antidepressants o Antiepileptic Drugs o Anti-Parkinson's Drugs • Others 3.2.3 By End-User • Pharmaceutical Companies o Branded Drug Manufacturers o Generic Drug Manufacturers • Biopharmaceutical Companies • Research Institutions 3.2.4 By Geography • North America o United States o Canada • Europe o Germany o France o United Kingdom o Rest of Europe • Asia Pacific o China o Japan o India o Rest of Asia Pacific • Latin America o Brazil o Rest of Latin America • Middle East & Africa (MEA) o GCC o South Africa o Rest of MEA 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. Global Pharmaceutical Chemicals Market by Chemical Type 4.1 Introduction 4.2 Market Size and Growth Rate by Chemical Type (2024–2030) 4.2.1 Active Pharmaceutical Ingredients (APIs) • Synthetic APIs • Biochemical APIs • Others 4.2.2 Excipients • Fillers • Binders • Preservatives 4.2.3 Intermediates • Bulk Intermediates • Fine Intermediates
6. Global Pharmaceutical Chemicals Market by End-User 6.1 Introduction 6.2 Market Size and Growth Rate by End-User (2024–2030) 6.2.1 Pharmaceutical Companies • Branded Drug Manufacturers • Generic Drug Manufacturers 6.2.2 Biopharmaceutical Companies 6.2.3 Research and Academic Institutes
7. Global Pharmaceutical Chemicals Market by Geography 7.1 Introduction 7.2 Market Size and Growth Rate by Region (2024–2030) 7.2.1 North America 7.2.2 Europe 7.2.3 Asia Pacific 7.2.4 Latin America 7.2.5 Middle East & Africa (MEA)
8. Competitive Landscape 8.1 Company Profiles 8.1.1 BASF SE (Germany) 8.1.2 Dow Inc. (United States) 8.1.3 Pfizer Inc. (United States) 8.1.4 Novartis AG (Switzerland) 8.1.5 Sanofi (France) 8.1.6 GlaxoSmithKline (United Kingdom) 8.1.7 AstraZeneca (United Kingdom) 8.1.8 Johnson & Johnson (United States) 8.1.9 Merck KGaA (Germany) 8.1.10 Lonza Group (Switzerland) 8.1.11 Gilead Sciences (United States) 8.1.12 Bayer AG (Germany) 8.1.13 Boehringer Ingelheim (Germany) 8.1.14 AbbVie Inc. (United States) 8.1.15 Amgen Inc. (United States)
9. List of Tables and Figures Tables 1. Market Size and Growth Rate by Chemical Type (2024–2030) 2. Market Size and Growth Rate by Therapeutic Application (2024–2030) 3. Market Size and Growth Rate by End-User (2024–2030) 4. Regional Market Share Analysis (2024–2030)
Figures 1. Global Pharmaceutical Chemicals Market Overview 2. Market Share by Chemical Type 3. Market Share by Therapeutic Application 4. Regional Market Dynamics
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Pharmaceutical Chemicals Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Pharmaceutical Chemicals Market for the past year and forecasts for the next six years. Global Pharmaceutical Chemicals Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Pharmaceutical Chemicals Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Pharmaceutical Chemicals Market from different application industries in different regions.
Segmentation Therapeutic Applications • Oncology o Anticancer Agents o Hormonal Therapies o Immunotherapeutic Compounds o Others • Cardiovascular Diseases o Antihypertensive Drugs o Anticoagulants o Antiarrhythmics • Infectious Diseases o Antibiotics o Antiviral Drugs • Others o Neurological Disorders o Endocrine Disorders
Chemical Type • Active Pharmaceutical Ingredients (APIs) o Synthetic Chemicals o Biochemical APIs o Others • Excipients o Binders o Fillers o Preservatives • Intermediates o Bulk Intermediates o Fine Intermediates
End-Use • Pharmaceutical Companies o Branded Drug Manufacturers o Generic Drug Manufacturers • Research and Development Institutions o Academic Research Centers o Contract Research Organizations (CROs) • Others o Biopharmaceutical Companies o Hospitals
